Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

被引：0

作者：

Poynton, Edward ^{[1
,2
]}

Chernucha, Emily ^{[3
]}

Day, James ^{[2
]}

Prodger, Catherine ^{[4
]}

Hopkins, David ^{[5
]}

Rakesh, Pallav ^{[5
,6
]}

O'Neill, Tess ^{[7
]}

Thakrar, Nisha ^{[2
]}

Akarca, Ayse ^{[8
]}

Jamal, Esraa ^{[1
]}

Ali, Ayesha ^{[9
]}

Kirkwood, Amy A. ^{[10
]}

Pomplun, Sabine ^{[8
]}

Marafioti, Teresa ^{[8
]}

Calaminici, Maria

Greaves, Paul ^{[11
]}

Chaganti, Sridhar ^{[6
]}

Mckay, Pam

Smith, Jeffery ^{[12
]}

Eyre, Toby A.

Martinez-Calle, Nicolas ^{[3
]}

Cwynarski, Kate ^{[2
]}

Fox, Christopher P. ^{[13
]}

Okosun, Jessica

机构：

[1] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England

[2] Univ Coll London Hosp, Dept Clin Haematol, London, England

[3] Nottingham Univ Hosp NHS Trust, Nottingham, England

[4] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England

[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[6] Univ Hosp Birmingham NHS Fdn Trust, Ctr Clin Haematol, Birmingham, W Midlands, England

[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haemato Oncol, London, England

[8] Univ Coll London Hosp, Dept Histopathol, London, England

[9] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England

[10] UCL, Canc Res UK, London, England

[11] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Haematol, London, England

[12] Liverpool Univ Hosp, Clatterbridge Canc Ctr, Liverpool, Merseyside, England

[13] Univ Nottingham, Sch Med, Nottingham, England

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

PCNSL; primary CNS Lymphoma; double expressor; MYC; BCL2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ABCL-184

引用

页码：S423 / S424

页数：2

共 50 条

[41] The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era
Wu, Yi-Fan
Yuan, Qun-Hui
Shen, Hao-Rui
Du, Kai-Xin
Shang, Chun-Yu
Li, Yue
Zhang, Xin-Yu
Wu, Jia-Zhu
Gao, Rui
Wang, Li
Li, Jian-Yong
Yin, Hua
Liang, Jin-Hua
Xu, Wei
CANCER SCIENCE, 2025, 116 (01) : 257 - 270
[42] Large B Cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma
Weiss, V. L.
Wang, X. J.
Medeiros, L. J.
Li, S.
MODERN PATHOLOGY, 2014, 27 : 385A - 385A
[43] Large B Cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma
Weiss, V. L.
Wang, X. J.
Medeiros, L. J.
Li, S.
LABORATORY INVESTIGATION, 2014, 94 : 385A - 385A
[44] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
Menguy, Sarah
Frison, Eric
Prochazkova-Carlotti, Martina
Dalle, Stephane
Dereure, Olivier
Boulinguez, Serge
Dalac, Sophie
Machet, Laurent
Ram-Wolff, Caroline
Verneuil, Laurence
Gros, Audrey
Vergier, Beatrice
Beylot-Barry, Marie
Merlio, Jean-Philippe
Pham-Ledard, Anne
MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
[45] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
Menguy, Sarah
Frison, Eric
Prochazkova-Carlotti, Martina
Dalle, Stephane
Dereure, Olivier
Boulinguez, Serge
Dalac, Sophie
Machet, Laurent
Ram-Wolff, Caroline
Verneuil, Laurence
Gros, Audrey
Vergier, Beatrice
Beylot-Barry, Marie
Merlio, Jean-Philippe
Pham-Ledard, Anne
EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
[46] The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy
Kawajiri, Akihisa
Maruyama, Dai
Maeshima, Akiko Miyagi
Makita, Shin-ichi
Kitahara, Hideaki
Miyamoto, Ken-ichi
Fukuhara, Suguru
Suzuki, Tatsuya
Munakata, Wataru
Kobayashi, Yukio
Tajima, Kinuko
Itami, Jun
Taniguchi, Hirokazu
Tobinai, Kensei
BLOOD, 2014, 124 (21)
[47] Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Lue, Jennifer K.
Luttwak, Efrat
Rivas-Delgado, Alfredo
Irawan, Helen
Boardman, Alexander
Caron, Philip C.
David, Kevin
Epstein-Peterson, Zachary
Falchi, Lorenzo
Ghione, Paola
Hamlin, Paul
Horwitz, Steven M.
Intlekofer, Andrew M.
Johnson, William
Kumar, Anita
Moskowitz, Alison
Noy, Ariela
Palomba, M. Lia
Steiner, Ralphael
Stuver, Robert
Torka, Pallawi
Vardhana, Santosha
Zelenetz, Andrew D.
Schoder, Heiko
Imber, Brandon
Yahalom, Joachim
Zhang, Yanming
Galera, Pallavi
Dogan, Ahmet
Aypar, Umut
Salles, Gilles
BLOOD CANCER JOURNAL, 2024, 14 (01):
[48] MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL
Shi, Qian-Yun
Feng, Xiao
Bao, Wei
Ma, Jie
Lv, Jing-Huan
Wang, Xuan
Rao, Qiu
Shi, Qun-Li
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (11): : 942 - 948
[49] THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT
Fraenza, C.
Bernasconi, R.
Parisi, A.
Tisi, M. C.
Riva, M.
Moretta, F.
Brighenti, A.
Ferrarini, I.
Tanasi, I.
Quaglia, F. M.
Krampera, M.
Visco, C.
HAEMATOLOGICA, 2021, 106 (10) : 90 - 90
[50] Prognostic Implications of MYC and BCL2 Expression in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System
Kim, Sehui
Nam, Soo Jeong
Kwon, Dohee
Kim, Hannah
Kim, Tae Min
Heo, Dae Seog
Park, Sung Hye
Kim, Chul Woo
Jeon, Yoon Kyung
MODERN PATHOLOGY, 2016, 29 : 356A - 356A

← 1 2 3 4 5 →